This is the authors' abstract. We don't add key points for this paper.
Dysthyroid orbitopathy is an autoimmune inflammatory disease of the orbital tissues associated with Graves’ disease, and rarely, Hashimoto’s disease. Symptoms include diplopia, rabbit eyes, decreased visual acuity, and cosmetic problems, such as protruding eyeballs. Our department has been performing endoscopic transnasal orbital decompression for dysthyroid orbitopathy since 2015. Orbital decompression is performed to relieve pressure on the optic nerve in severe cases, and also to resolve cosmetic problems such as protrusion of the eyes in mild to moderate cases. Surgery is usually performed bilaterally, and there are very few reports of unilateral orbital decompression. Herein, we report performing an endoscopic transnasal orbital decompression procedure to improve eye closure difficulties and improve the appearance in an inactive, mild case with unilateral thyroid ophthalmopathy. The patient was an 18-year-old woman who was diagnosed as having Graves’ disease 6 years before her first visit to our department. She developed dysthyroid orbitopathy 3 years before her first visit to our department and was treated with steroid pulses and botox injections at the neuro-ophthalmology department. She had undergone total thyroidectomy 1 year before her first visit to our department. She was referred to our department and underwent right orbital decompression surgery. After the surgery, the protrusion of the eyeballs decreased by 3 mm, and the subjective symptom of difficulty in closing the eye also improved. Also, diplopia is the main postoperative complication of endoscopic transnasal orbital decompression. In this case, however, there was no diplopia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tsuda et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: